Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection U.S. Official Order Forms for Schedules I and II Controlled Substances DEA Form 222, 61251 [2016-21297]

Agencies

• Department of Justice

[Federal Register Volume 81, Number 172 (Tuesday, September 6, 2016)]
[Notices]
[Page 61251]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-21297]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

[OMB Number 1117-0010]


Agency Information Collection Activities; Proposed eCollection, 
eComments Requested; Extension Without Change of a Previously Approved 
Collection U.S. Official Order Forms for Schedules I and II Controlled 
Substances DEA Form 222

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: 30-day notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Justice (DOJ), Drug Enforcement 
Administration (DEA), will submit the following information collection 
request to the Office of Management and Budget (OMB) for review and 
approval in accordance with the Paperwork Reduction Act of 1995. This 
proposed information collection was previously published in the Federal 
Register at 81 FR 42726, June 30, 2016, allowing for a 60 day comment 
period.

DATES: Comments are encouraged and will be accepted for an additional 
30 days until October 6, 2016.

FOR FURTHER INFORMATION CONTACT: If you have comments on the estimated 
public burden or associated response time, suggestions, or need a copy 
of the proposed information collection instrument with instructions or 
additional information, please contact Michael J. Lewis, Office of 
Diversion Control, Drug Enforcement Administration; Mailing Address: 
8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (202) 
598-6812 or sent to OIRA_submissions@omb.eop.gov.

SUPPLEMENTARY INFORMATION: Written comments and suggestions from the 
public and affected agencies concerning the proposed collection of 
information are encouraged. Your comments should address one or more of 
the following four points:

--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of 
the information proposed to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other forms of information technology, e.g., 
permitting electronic submission of responses.

Overview of This Information Collection

    1. Type of Information Collection: Extension of a currently 
approved collection.
    2. Title of the Form/Collection: U.S. Official Order Forms for 
Schedules I and II Controlled Substances.
    3. The agency form number, if any, and the applicable component of 
the Department sponsoring the collection: DEA Form: 222. The applicable 
component within the Department of Justice is the Drug Enforcement 
Administration, Office of Diversion Control.
    4. Affected public who will be asked or required to respond, as 
well as a brief abstract:
    Affected public (Primary): Business or other for-profit.
    Affected public (Other): Not-for-profit institutions; Federal, 
State, local, and tribal governments.
    Abstract: The Controlled Substances Act (CSA) (21 U.S.C. 801-971) 
establishes a closed system of distribution for controlled substances. 
To this end, controlled substances are closely monitored and tightly 
regulated as they are distributed through the supply chain. One tool 
that helps to maintain the closed system of distribution is the CSA 
provision that states it ``shall be unlawful for any person to 
distribute a controlled substance in schedules I or II to another 
except in pursuance of a written order of the person to whom such 
substance is distributed, made on a form to be issued by the Attorney 
General in blank in accordance with subsection (d) of this section..'' 
21 U.S.C. 828(a).
    5. An estimate of the total number of respondents and the amount of 
time estimated for an average respondent to respond: The DEA estimates 
that 125,435 registrants participate in this information collection, 
taking an estimated 11.6 hours per registrant annually.
    6. An estimate of the total public burden (in hours) associated 
with the proposed collection: The DEA estimates that this collection 
takes 1,453,348 annual burden hours.
    If additional information is required please contact: Jerri Murray, 
Department Clearance Officer, United States Department of Justice, 
Justice Management Division, Policy and Planning Staff, Two 
Constitution Square, 145 N Street NE., Suite 3E.405B, Washington, DC 
20530.

    Dated: August 31, 2016.
Jerri Murray,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2016-21297 Filed 9-2-16; 8:45 am]
BILLING CODE 4410-09-P